Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: Results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial

American Heart Journal

Volumn 161, Issue 2, 2011, Pages

  Caixeta, Adriano ^a,c   Dangas, George D ^a,b   Mehran, Roxana ^a,b   Feit, Frederick ^e   Nikolsky, Eugenia ^a,c   Lansky, Alexandra J ^d   Aoki, Jiro ^a,c   Moses, Jeffrey W ^a,c   Steinhubl, Steven R ^f   White, Harvey D ^g   Ohman, E Magnus ^h   Manoukian, Steven V ⁱ   Fahy, Martin ^c   Stone, Gregg W ^a,c  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c Department of Medicine   (United States)

^d YALE UNIVERSITY MEDICAL CENTER   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ HOSPITAL CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG;

ACQUIRED THROMBOCYTOPENIA; ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIAC PATIENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 79951485629     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.10.035     Document Type: Article

References (22)

1. Anderson J.L., Adams C.D., and Antman E.M. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction-Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 652 726
2. Bassand J.P., Hamm C.W., and Ardissino D. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
3. Merlini P.A., Rossi M., and Menozzi A. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting Circulation 109 2004 2203 2206 (Pubitemid 38625397)
4. Nikolsky E., Sadeghi H.M., and Effron M.B. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction Am J Cardiol 96 2005 474 481 (Pubitemid 41132760)
5. McClure M.W., Berkowitz S.D., and Sparapani R. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience Circulation 99 1999 2892 2900 (Pubitemid 29258977)
6. Eikelboom J.W., Anand S.S., and Mehta S.R. Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) study Circulation 103 2001 643 650 (Pubitemid 32144191)
7. Eikelboom J.W., Mehta S.R., and Anand S.S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
8. Rao S.V., O'Grady K., and Pieper K.S. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206 (Pubitemid 41505393)
9. Manoukian S.V., Feit F., and Mehran R. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial J Am Coll Cardiol 49 2007 1362 1368 (Pubitemid 46476844)
10. Lincoff A.M., Bittl J.A., and Harrington R.A. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863 (Pubitemid 37430344)
11. Stone G.W., McLaurin B.T., and Cox D.A. Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216 (Pubitemid 44791162)
12. Kratz A., Ferraro M., and Sluss P.M. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values N Engl J Med 351 2004 1548 1563
13. Wang T.Y., Ou F.S., and Roe M.T. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice Circulation 119 2009 2454 2462
14. Chesebro J.H., Knatterud G., and Roberts R. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76 1987 142 154 (Pubitemid 17093202)
15. Stone G.W., Witzenbichler B., and Guagliumi G. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
16. Berkowitz S.D., Sane D.C., and Sigmon K.N. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) study group J Am Coll Cardiol 32 1998 311 319 (Pubitemid 28396477)
17. Yeh R.W., Wiviott S.D., and Giugliano R.P. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes Am J Cardiol 100 2007 1734 1738 (Pubitemid 350245374)
18. Oliveira G.B., Crespo E.M., and Becker R.C. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy Arch Intern Med 168 2008 94 102
19. Kereiakes D.J., Berkowitz S.D., and Lincoff A.M. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade Am Heart J 140 2000 74 80 (Pubitemid 30471244)
20. Spencer F.A., Moscucci M., and Granger C.B. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801 (Pubitemid 350291221)
21. Feit F., Voeltz M.D., and Attubato M.J. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial Am J Cardiol 100 2007 1364 1369 (Pubitemid 47576015)
22. Mehran R., Pocock S.J., and Stone G.W. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-\ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466